Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

Juno Medical's core mission is centered around revolutionizing healthcare technology by developing innovative solutions that improve patient outcomes and streamline medical processes. Their primary objective is to empower healthcare providers and organizations with cutting-edge tools and systems, enabling them to deliver exceptional care and enhance overall efficiency. By fostering a culture of collaboration and continuous improvement, Juno Medical strives to transform the healthcare landscape and create a lasting impact on the well-being of communities worldwide.

• Patient-centered care: Juno Medical prioritizes the needs and well-being of patients, providing compassionate and personalized care that is tailored to each individual's unique circumstances.
• Collaborative teamwork: Juno Medical values collaboration and teamwork, fostering a supportive and inclusive environment where employees work together to achieve common goals.
• Continuous improvement: Juno Medical is committed to continuous improvement, encouraging employees to seek out new knowledge and skills and to embrace change as a means of enhancing patient care.
• Integrity and accountability: Juno Medical operates with integrity and accountability, upholding the highest ethical standards and taking responsibility for its actions and decisions.